Scott Powell | IR |
Cameron Reynolds | CEO |
Dr. Tom Butera | CEO, Volition Veterinary |
Terig Hughes | CFO |
Ross Osborn | Cantor Fitzgerald |
Bruce Jackson | The Benchmark Company |
Nathan Weinstein | Aegis Capital |
Steven Ralston | Zacks |
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to VolitionRx Limited's Second Quarter '22 Earnings Conference Call. [Operator Instructions] This conference is being recorded today, August 11, 2022. I'd now like to turn the conference over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead.